The Mexican government will continue to buy public sector drugs from Salud from Mexican companies as long as they do not raise prices, said President Andres Manuel López Obrador.
The head of the federal government announced this yesterday morning saw a delivery methotrexate for the treatment of cancer.
Medicines continue to be purchased in Mexico if they are offered at fair prices and there are adequate care options. We will not buy the drugs for 200%, 300% more than they really are worth in the labs, that's over, "López Obrador said.
The President insisted that his administration do everything necessary to procure the medicines to deliver highly specialized hospitals to treat diseases such as cancer.
We will buy medicines all over the world. No sabotage, corruption is over, "said the Federal President.
He affirmed that businessmen should not take advantage of the state's need to provide hospitals with medication.
Of course, whoever wants to do business is allowed but with adequate resources, is that these were insatiable, and the only justification they give is that they have delivered moches to have these contracts, that is, they had to bribe the authorities, we will not allow bribery any more. " said the president.
NO MORE BOYCOTT
The President told Oxkutzcab, Yucatán, that the cancer drug that had arrived yesterday was acquired in France.
He insisted that imports of medicines would end the shortage of drugs used by the companies that supplied them and launch a campaign against the federal government, as they did not benefit from contracts.
They wanted to boycott, not sell medicines to cure children with cancer, and thought they wanted to turn us. Well, what did we do? Medicines have already been purchased in France … The medicines bought abroad have arrived so they do not lack medicines.
He accused three companies that were not even laboratories and controlled the supply of medicines in public health.
López Obrador ended the visit of 60 rural hospitals of the IMSS welfare system across the country this weekend.
MEDICINE AGAINST CANCER BORN FROM FRANCE
The price at which the Mexican government purchased methotrexate from the Mylan laboratory was "marginally lower" than the price the previous government had granted to the Ministry of Health. [1
It is important to note that these prices were 82 and 254.7 pesos, respectively, compared to those paid by the administration to the only laboratory that produced them, "Health acknowledged, but noted that the price of the laboratory "includes the transfer France-Mexico. "
In a statement he stated that 38 thousand 200 units (29 thousand 230 of 50 mg and 8 thousand 970 of 500 mg) were purchased, representing" the need to cover all of the sector for the rest of the year.
He added that the Marine Secretariat consolidated the requirements of the healthcare system (which includes IMSS, ISSSTE, national institutes, highly specialized and state hospitals).
He noted that the purchase was made to Mylan's lab, which is considered one of the top three generics companies in the world.
The purchase of the drug took place in the factory in France in which it existed. In addition to the registration of the European Health Authority, which is recognized by the World Health Organization to the highest standards, he added health to the inventory.
He added that Marina was responsible for the internment at his customs agent and it is distributed to the institutions of the health sector according to medical needs.
In peripheral areas, 15% more for doctors
The Mexican Social Security Institute (IMSS) will increase the salary for doctors working in areas classified as "difficult" by 15%, said the headline, Zoé Robledo.
Compensation will be based on the net salary for the additional living expenses incurred for working in remote communities of major cities.
Robledo said that one of the four conditions must be met Set up for this purpose.
From the last day of September, until the first half of September, physicians specializing in the first stage of the IMSS Welfare Program will receive additional compensation, "Zoé Robledo said.
four variables used to calculate the salary increase of first-level specialists.
The first, the distance between the community where the hospital is located and the state capital. Second: access to communication channels. Third, what is the index of human development of the place, what is its index of poverty, of marginalization? "Said the head of IMSS.
The fourth variable has to do with the uncertainty that results from living in several areas of the country.
Fourth, the question of uncertainty. In many cases, high-profile physicians do not want to go because they are dangerous, "admitted Robledo.